Close
Achema middle east

Yuvraj

Community verified biological network models show promise for toxicology and drug discovery

A new set of community-produced biological network models has been shown to allow a deeper understanding of the mechanisms underlying a range of diseases....

Boehringer Ingelheim: Growth in all core businesses

Boehringer Ingelheim reported currency-adjusted growth in all its core businesses in the first half of 2016. At the same time, the research-driven pharmaceutical company...

Novartis CDK4/6 inhibitor LEE011 receives FDA Breakthrough Therapy designation as first-line treatment for advanced breast cancer

Novartis announced today that the US FDA has granted Breakthrough Therapy designation to LEE011 (ribociclib), in combination with letrozole, for the treatment of hormone...

OPTIMA Nonwovens at FachPack 2016

Optima has expanded its machine range to include new entry-level solutions. These solutions currently include the flexible and completely attuned filling and closing machines...

Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration

Amgen and Advaxis, Inc announced a global agreement for the development and commercialization of Advaxis' ADXS-NEO, a novel, preclinical investigational cancer immunotherapy treatment that...

Aphena Relocates and Expands Chocolated Manufacturing Operations to Fourfold Increase in Production Capacity

Aphena Pharma Solutions is pleased to announce the relocation and major expansion of our chocolated pharmaceutical manufacturing operations.   Offerings include brand-equivalent formulations of...

Kyowa Hakko Kirin Completed of Construction for the Biopharmaceutical API Manufacturing Facility in the Takasaki Plant

Kyowa Hakko Kirin Co Ltd has completed the construction of the HB6 Plant in the Takasaki Plant (Takasaki city, Gunma, Plant Manager: Hitoshi Arai)...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »